Published in
BioMed Central, Journal of Translational Medicine, Suppl 1(13), p. O5
DOI: 10.1186/1479-5876-13-s1-o5
Links
- ORCID
- BioMed Central | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
Journal article published in 2015 by
F. Stephen Hodi,
Reinhard Dummer,
Adil Daud,
Igor Puzanov 
,
Omid Hamid,
Dirk Schadendorf,
Caroline Robert,
Jacob Schachter,
Hodi Fs,
Anna Pavlick,
Rene Gonzalez,
F. Hodi,
Cranmer Ld,
Lee D. Cranmer,
Christian Blank
and other authors.
,
Omid Hamid,
Dirk Schadendorf,
Caroline Robert,
Jacob Schachter,
Hodi Fs,
Anna Pavlick,
Rene Gonzalez,
F. Hodi,
Cranmer Ld,
Lee D. Cranmer,
Christian Blank
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 